AbstractTo evaluate the role of oncogenic RAS mutations in pancreatic tumorigenesis, we directed endogenous expression of KRASG12D to progenitor cells of the mouse pancreas. We find that physiological levels of KrasG12D induce ductal lesions that recapitulate the full spectrum of human pancreatic intraepithelial neoplasias (PanINs), putative precursors to invasive pancreatic cancer. The PanINs are highly proliferative, show evidence of histological progression, and activate signaling pathways normally quiescent in ductal epithelium, suggesting potential therapeutic and chemopreventive targets for the cognate human condition. At low frequency, these lesions also progress spontaneously to invasive and metastatic adenocarcinomas, establishing ...
SummaryStromal responses elicited by early stage neoplastic lesions can promote tumor growth. Howeve...
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading forms of cancer related deaths in the ...
BACKGROUND & AIMS: Activating mutation of the KRAS gene is common in some cancers, such as pancreati...
AbstractTo evaluate the role of oncogenic RAS mutations in pancreatic tumorigenesis, we directed end...
AbstractPancreatic intraepithelial neoplasia (PanIN) is the most common premalignant lesion of the p...
SummaryPancreatic ductal adenocarcinoma (PDA), one of the deadliest human cancers, often involves so...
AbstractPancreatic intraepithelial neoplasia (PanIN) is the most common premalignant lesion of the p...
Pancreatic duct ligation (PDL) in the murine model has been described as an exocrine pancreatic atro...
Pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions, pancreatic intraepithelial neopla...
Molecular events occurring in stepwise progression from pre-malignant lesions (pancreatic intraepith...
Molecular events occurring in stepwise progression from pre-malignant lesions (pancreatic intraepith...
SummaryPancreatic ductal adenocarcinoma (PDA), one of the deadliest human cancers, often involves so...
Molecular events occurring in stepwise progression from pre-malignant lesions (pancreatic intraepith...
Pancreatic ductal adenocarcinoma (PDA) is a deadly disease with few treatment options. There is an u...
Background: Pancreatic cancer is among the most dismal of human malignancies. The 5-year survival ra...
SummaryStromal responses elicited by early stage neoplastic lesions can promote tumor growth. Howeve...
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading forms of cancer related deaths in the ...
BACKGROUND & AIMS: Activating mutation of the KRAS gene is common in some cancers, such as pancreati...
AbstractTo evaluate the role of oncogenic RAS mutations in pancreatic tumorigenesis, we directed end...
AbstractPancreatic intraepithelial neoplasia (PanIN) is the most common premalignant lesion of the p...
SummaryPancreatic ductal adenocarcinoma (PDA), one of the deadliest human cancers, often involves so...
AbstractPancreatic intraepithelial neoplasia (PanIN) is the most common premalignant lesion of the p...
Pancreatic duct ligation (PDL) in the murine model has been described as an exocrine pancreatic atro...
Pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions, pancreatic intraepithelial neopla...
Molecular events occurring in stepwise progression from pre-malignant lesions (pancreatic intraepith...
Molecular events occurring in stepwise progression from pre-malignant lesions (pancreatic intraepith...
SummaryPancreatic ductal adenocarcinoma (PDA), one of the deadliest human cancers, often involves so...
Molecular events occurring in stepwise progression from pre-malignant lesions (pancreatic intraepith...
Pancreatic ductal adenocarcinoma (PDA) is a deadly disease with few treatment options. There is an u...
Background: Pancreatic cancer is among the most dismal of human malignancies. The 5-year survival ra...
SummaryStromal responses elicited by early stage neoplastic lesions can promote tumor growth. Howeve...
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading forms of cancer related deaths in the ...
BACKGROUND & AIMS: Activating mutation of the KRAS gene is common in some cancers, such as pancreati...